Drug Interaction with Cyclosporine and Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for HCV in Organ Transplant Recipients
碩士 === 國立陽明大學 === 藥理學研究所 === 106 === Background: Hepatitis C virus (HCV) infection affects millions of individuals worldwide, especially for those who have received organ transplantation. Direct-acting antiviral agents (DAAs) as a combination regimen to treat chronic HCV infection have been proven t...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/2qhqsa |